Results 141 to 150 of about 23,600 (247)

Real-world disease characteristics and frontline treatments used in chronic lymphocytic leukaemia in Bulgaria: An observational cohort study (DESCRIBE). [PDF]

J Int Med Res
Graklanov V, Radinoff A, Micheva I, Efraim ME, Donchev M, Yankova T, Slavcheva-Popova V, Naneva S, Hadjiev E, Gercheva-Kyuchukova L, Petrova-Latkova M, Nikolov I, Nenov A, Ostojić A, Krasteva S, Grudeva-Popova Z.   +15 more
europepmc   +1 more source

Complex genetic landscape in CLL: Clinical impact on patients' survival and insights into the altered molecular pathways. [PDF]

Mol Ther Oncol
Caputo C, Donadelli M, Scupoli M, D'Arena G, Pietrantuono G, Giudice A, Giliberti A, Volpe S, Sperlongano R, Cautela D, Scafuri B, Facchiano A, Cossu AM, Bocchetti M, Misso G, Lombardi A, Caraglia M, Grimaldi A.   +17 more
europepmc   +1 more source

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL.

Blood
Burger JA, Barr PM, Robak T, Owen C, Tedeschi A, Sarma A, Patten PEM, Grosicki S, McCarthy H, Offner F, Szafer-Glusman E, Zhou C, Szoke A, Neumayr L, Dean JP, Ghia P, Kipps TJ.   +16 more
europepmc   +1 more source

Quantum Chemical Studies of Anti-Blood Cancer Agents, II. [PDF]

ACS Omega
Boča R, Štofko J, Ladická M, Rajnák C.   +3 more
europepmc   +1 more source

BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders. [PDF]

Biomolecules
Duminuco A, De Luca P, Stanzione G, Caruso LA, Lavenia G, Scarso S, Garibaldi B, Palumbo FE, Vetro C, Palumbo GA.   +9 more
europepmc   +1 more source

Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia [PDF]

Barker, Campbell, Christopher, Cotter, Dunn, Gleich, Jackson, Kohn, Lutz, Meichner, Mitchell, Naik, O'Neill, Ottenjann, Piek, Piek, Piek, Reimer, Roumier, Ruple-Czerniak, Scott, Stockham, Swann, Tasker, Tasker, Vagace, Visco, Wardrop, Weinkle, Weiss, Weiss, Werner   +31 more
core   +1 more source

ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro [PDF]

, 2015
Ademokun, JA, Norton, JD, Weiler, S
core   +1 more source

Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN.

Blood
Sharman JP, Egyed M, Jurczak W, Skarbnik A, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliatto LM, Herishanu Y, Banerji V, Follows G, Walker P, Ghia P, Janssens A, Byrd JC, Ferrant E, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Miranda P, Munugalavadla V, Wun CC, Woyach JA.   +26 more
europepmc   +1 more source

High-content imaging of primary chronic lymphocytic leukemia cells predicts patient cohorts with distinct cellular drug responses. [PDF]

iScience
Li MX, Brito GC, Ylanko J, Buzina A, Leber B, Usta S, Tsui H, Spaner DE, Andrews DW.   +8 more
europepmc   +1 more source

Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity.

Bioorganic & Medicinal Chemistry Letters, 2017
Rui Xie, Yan Li, Pingwah Tang, Qipeng Yuan   +3 more
semanticscholar   +1 more source